The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunotherapy in RAS mutant mCRC: Could CTLA-4 blockade increase the efficacy of anti PD-1 agents? Preliminary clinical results of the NERDY study.
 
Alessandra Anna Anna Prete
No Relationships to Disclose
 
Rossana Intini
No Relationships to Disclose
 
Vittoria Matilde Piva
No Relationships to Disclose
 
Valentina Angerilli
No Relationships to Disclose
 
Francesca Daniel
No Relationships to Disclose
 
Giulia Barsotti
No Relationships to Disclose
 
Maria Caterina De Grandis
No Relationships to Disclose
 
Krisida Cerma
No Relationships to Disclose
 
Giada Munari
No Relationships to Disclose
 
Gianmarco Ricagno
No Relationships to Disclose
 
Aldo Montagna
No Relationships to Disclose
 
Chiara De Toni
No Relationships to Disclose
 
Silvia Rossi
No Relationships to Disclose
 
Riccardo Cerantola
No Relationships to Disclose
 
Cosimo Rasola
No Relationships to Disclose
 
Francesca Schiavi
No Relationships to Disclose
 
Matteo Fassan
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Diaceutics; Diaceutics; GlaxoSmithKline; MSD Oncology; Roche; Tesaro
Research Funding - Astellas Pharma; Macrophage Pharma; QED Therapeutics
 
Francesca Bergamo
No Relationships to Disclose
 
Vittorina Zagonel
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer; Mundipharma
Speakers' Bureau - Astellas Pharma; Bayer; Merck
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo/Lilly
 
Sara Lonardi
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Incyte; Lilly; Merck Serono; Mirati Therapeutics; MSD; SERVIER
Speakers' Bureau - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; Mirati Therapeutics; MSD Oncology; Pierre Fabre; Roche; Servier
Research Funding - Amgen; AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Lilly (Inst); Merck Serono; Roche (Inst)